James Merson insider trades

Open-market stock purchases and sales by James Merson, Director at Cidara Therapeutics, Inc, from SEC Form 4 filings since Apr 26, 2024.

Recent trades

DateStockTradeValue
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$53.7K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$26.9K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$237K

Companies traded

  • CDTX Cidara Therapeutics, Inc: other filings, last Jan 7, 2026

Get free alerts when James Merson files a new trade →